0001209191-21-002422.txt : 20210106
0001209191-21-002422.hdr.sgml : 20210106
20210106211514
ACCESSION NUMBER: 0001209191-21-002422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210106
DATE AS OF CHANGE: 20210106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosen Karin
CENTRAL INDEX KEY: 0001831048
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 21512750
MAIL ADDRESS:
STREET 1: C/O HORIZON THERAPEUTICS, INC.
STREET 2: CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
CITY: DUBLIN
STATE: L2
ZIP: D04 C5Y6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-04
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001831048
Rosen Karin
C/O HORIZON THERAPEUTICS, INC.
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
D04 C5Y6
IRELAND
0
1
0
0
EVP, R&D & CSO
Restricted Stock Units (RSU)
2021-01-04
4
A
0
24449
0.00
A
Ordinary Shares
24449
24449
D
Each RSU represents a contingent right to receive one ordinary share of the Issuer.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
/s/ Miles W. McHugh, Attorney-in-Fact
2021-01-06